Immunogen Stock Price, News & Analysis

IMGN NASDAQ

Company Description

Immunogen (NASDAQ: IMGN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

IMGN stock has declined 100.0% over the past year.

This page provides a comprehensive overview of IMGN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

279.4M

Shares outstanding

Immunogen (IMGN) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

November 5, 2024

0.00%

Seaport Therapeutics Names Lauren White as Chief Financial Officer

February 12, 2024

0.00%

AbbVie Completes Acquisition of ImmunoGen

acquisition

February 1, 2024

-0.34%

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 3, 2024

+0.07%

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 10, 2023

+1.51%

ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH

clinical trial

December 5, 2023

-0.03%

FDA Grants Priority Review of ImmunoGen’s Supplemental Biologics License Application for ELAHERE® (mirvetuximab soravtansine-gynx) in Platinum-Resistant Ovarian Cancer

fda approval

Immunogen has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial, fda approval, earnings. View all IMGN news →

SEC Filings

View All

No SEC filings available for IMGN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMGN Company Profile & Sector Positioning

Immunogen (IMGN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.